This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Bells Palsy Treatment Market

Bells Palsy Treatment Market

Bell’s Palsy Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2028

Bells Palsy Treatment Market
FACT1291MR

Introduction

Bell’s palsy is a chronic medical condition that causes temporary weakness or paralysis of the facial muscles. Bell’s palsy generally occurs when the nerves that control the facial muscles become inflamed, swollen, or compressed. Patients suffering from Bell’s palsy find it difficult to smile or close their eyes as it affects one side of face. Bell’s palsy is common among people aged between 16 to 60 years. It usually occurs after the patient suffers from cold, ear infection or eye infection for one or two weeks or more. However, the exact cause of damage of the cranial nerve due to Bell’s palsy is still unknown. Patients suffering from diabetes or lung infection are highly susceptible to Bell’s palsy.

Bell’s palsy is diagnosed by various blood tests to check the presence of bacterial or viral infection. MRI or CT is also used for the final diagnosis of Bell’s palsy by scanning the nerves of patients. Corticosteroids and anticonvulsants are used as the first line of treatment by physicians for the treatment of Bell’s palsy. These drugs are given in combination with anti-bacterial medications and anti-viral medications. Over-the-counter pain medications, such as ibuprofen or acetaminophen, can also be used by patients for temporary relief from Bell’s palsy. Moreover, eye drops and ear drops are also used along with these medications if the root cause of Bell’s palsy is ear or eye infection. Various home remedies are also used by patients to manage Bell’s palsy, such as facial massage, physical therapy exercises, a warm & moist towel over your face to relieve pain, etc.

Bell’s Palsy Treatment Market: Drivers and Restraints

The primary factor driving the Bell’s palsy treatment market is the increasing prevalence of ear and eye infections, which are the major causes of Bell’s palsy. Moreover, unfavourable changes in the lifestyles of people is also boosting the prevalence of Bell’s palsy. Rising awareness among the people about the Bell’s palsy treatment is also expected to increase its demand over the forecast period. In addition, high focus of leading pharmaceutical companies to manufacture the more improved drugs for Bell’s palsy treatment will also be responsible for the robust growth of this market. On other hand, the ignorance of patients about opting for Bell’s palsy treatment during the early onset of the disease is likely to restrain market growth. Moreover, lack of approved drugs for the appropriate Bell’s palsy treatment is also likely to hamper the growth of this market to a certain extent.

Bell’s Palsy Treatment Market: Overview

The Bell’s palsy treatment market is expected to witness exponential growth over the forecast period owing the rising prevalence of Bell’s palsy. According to some studies, the annual incidence of Bell’s palsy is 15-30 cases per 100,000 population. Bell’s palsy is most prevalent among the geriatric population.

The leading drug manufacturers of Bell’s palsy treatment are focus to develop more improved drugs to boost their market share. Large funding is provided by investors and the government for research and development to develop more appropriate drugs for Bell’s palsy treatment. By drug class, corticosteroids and anticonvulsants are expected to collectively gain majority of the revenue share of the global Bell’s palsy treatment market. Among all end users, online pharmacies is the fastest-growing segment due to the rising adoption of e-commerce.

Bell’s palsy Treatment Market: Regional Outlook

Geographically, the global Bell’s palsy treatment market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to gain maximum market share in terms of revenue owing to awareness among the people about Bell’s palsy treatment. The North America Bell’s palsy treatment market is followed by Western Europe and Eastern Europe owing to the presence of the maximum number of pharmaceutical companies in these regions. The Asia-Pacific excluding Japan region is expected to grow at a faster rate as compared to other regions due to the rising incidence of Bell’s palsy. In APEJ, Bell’s palsy is most prevalent in India and China. However, Latin America and Middle East & Africa are expected witness delayed growth due to lack of awareness among the people in these regions.

Avail customized purchase options for your needs

Bell’s Palsy Treatment Market: Key Players

Some of the key players operating in the global Bell’s palsy treatment market are Pfizer Inc.; Bristol-Myers Squibb and Company; Eli Lily and Company; Johnson & Johnson Services, Inc.; GlaxoSmithKline PLC; Bayer AG; Sanofi S.A.; Novartis AG; Teva Pharmaceutical Industries Ltd. and Gilead Sciences, Inc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

An Adaptive Approach to Modern-day Research Needs

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Interested to Procure The Data

Bell’s Palsy Treatment Market: Segmentation

The global Bell’s palsy treatment market can be segmented on the basis of drug class, distribution channel and geography.

Based on drug class type, the global Bell’s palsy treatment market is segmented as:

  • Corticosteroids
  • Anticonvulsants
  • Antibacterial
  • Antivirals
  • Others
  • Others

Based on distribution channel, the global Bell’s palsy treatment market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Movement Disorder Market

[170 Pages Report] Movement Disorder Market research report segmented By Product Types (Rechargeable...

Transcatheter Pacing System Market

Transcatheter Pacing System Market research report covers detailed information on Global Transcathet...

Lyophilization services Market

Lyophilization services Market research report covers detailed information on Global Lyophilization ...

Pelvic Floor Electrical Stimulation Devices Market

Global pelvic floor electrical stimulation devices market size will expand at over 9% CAGR from 2020...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.